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Background: Tuberculosis still remains a major public health concern in several provinces of the Democratic
Republic of Congo, especially in prison settings. The present study aimed at determining tuberculosis (TB)
prevalence and associated risk factors in inmates of the Mbuji-Mayi Central Prison.
Methods: This cross-sectional study was performed over a 6-month period (January to June 2015) in Mbuji-Mayi
Central Prison. A total of 733 inmates were screened systematically for TB. The diagnosis was based on clinical
examination and bacteriological tests.
Results: Tuberculosis was diagnosed in 130 inmates, what amounts to a 17.7 % prevalence (95 % confidence
interval [CI] 15.1–20.6 %). The mean age ± SD of infected inmates was 31 ± 9.5 years old, and 94.8 % of them
were male. Inmates were detained for a median period of 24 months (range: 3 months to 12 years). A cough
lasting more than 2 weeks, body temperature higher than 39 °C, and weight loss were the predominating clinical
signs. Factors independently associated with TB infection were overcrowding; highest population attributable
fraction ([PAF] 88.2 %; adjusted odds ratio [OR] 9.8 [95 % CI 3.1–31.6]); malnutrition (body mass index of less than
18.5 kg/m2) (PAF 35.6 %; adjusted OR 2.1 [1.3–3.0]); and a detention period equal to or greater than 12 months
(PAF 38.7 %; adjusted OR 2.1 [1.4–3.1]).
Conclusions: Improving detention and sanitary conditions, as well as providing an adequate and early
healthcare, are urgently needed to reduce TB prevalence in the prison environment.
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Despite being on the wane over the past few years, tu-
berculosis (TB) remains a lethal transmissible disease
around the world [1]. According to the World Health
Organization (WHO), 9.6 million people were infected
by TB in 2014 and 1.5 million died of the disease [2]. In
Africa, the situation has become alarming in the last few
years due to the poor socioeconomic context and to the* Correspondence: guikalonji@yahoo.fr
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fections. At least 80 % of TB patients live in sub-Saharan
Africa and in Asia. More than 95 % of deaths caused by
TB occur in low- and middle-income countries. Tuber-
culosis is taking on alarming proportions in the prison
environment, as poor conditions of detention facilitate
its transmission. Indeed, the risk of TB infection would
be 100 times greater in prison than in communities [3, 4].
Prison environment is often characterized by overcrowd-
ing, nutritional deficiencies, and inadequate healthcare;
these factors turn prison into a perfect breeding ground
for TB dissemination [5]. In Africa, TB is endemic,le is distributed under the terms of the Creative Commons Attribution 4.0
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Republic of Congo (DRC) is one of the countries most
affected. According to the WHO, the annual incidence
reached 325 cases per 100,000 population (116,894 new
TB cases) with a prevalence of 532 cases for every 100,000
inhabitants in 2014; the case-fatality rate was estimated at
69 per 100,000 population [2]. In DRC, TB control is coor-
dinated by the National TB Control Programme. In 2015,
the Kasaï-Oriental Coordination registered 13,341 TB
cases, all clinical forms included, in Mbuji-Mayi [9]. The
first national survey on resistance to anti-TB drugs was
implemented in July 2015; its preliminary results identified
Mbuji-Mayi as being the region the most affected by re-
sistant TB, with a prevalence of 15 and 37 % in new cases
and former patients, respectively [9]. Prevalence of resist-
ance is three times and five times above the national aver-
age in, respectively, former and newly diagnosed patients
[9]. Prison settings have been often identified as important
but neglected reservoirs for TB [10]. Most studies con-
ducted on TB in Africa prisons showed higher prevalence
of smear-positive pulmonary TB in prisons compared to
in the civilian population [11–14]. The present study
aimed at determining the prevalence of TB and associated
risk factors in the Mbuji-Mayi Central Prison. To our
knowledge, no study has ever investigated these parame-
ters in the country to date. This work highlights the ne-
cessity of screening any inmate upon admission and of
improving conditions of detention, in order to significantly
reduce TB prevalence; indeed, preventive measures and
treatment may be implemented.
Methods
Study setting
The study was performed in the Mbuji-Mayi Central
Prison, municipality of Diulu, one of the five urban units of
Mbuji-Mayi (former Kasaï Oriental province, now divided
into three administrative regions), DRC. The prison was
built in 1952 and was originally designed to accommodate
150 inmates, but more than 800 prisoners were jailed in
2014 [15]. These old buildings consist of eight dorms (no
light nor ventilation in them), each housing around 70 in-
mates, and several administrative offices.
Population and type of study
This cross-sectional study included 733 inmates, system-
atically screened for TB over a 6-month period (from
January 1 until June 30, 2015).
Inclusion criteria
All prison inmates were involved in the study, including
TB patients under treatment before screening. Any
clinical suspicion of TB was confirmed by bacteriology
(positive microscopy), and anti-TB therapy was imme-
diately started.Data collection
Data were collected by health professionals assigned to
the prison medical center; they were previously informed
on the terms of the survey and organizational measures,
as well as on personal protective equipment, mandatory
to prevent any contamination (respiratory mask, gloves,
and overalls). Investigators were required to be up to date
with vaccination. Every prisoner was examined and further
questioned by investigators: general, sociodemographic,
clinical, and epidemiological data were collected through a
structured questionnaire (pretested before starting the in-
vestigation). The diagnosis was based on clinical and para-
clinical data. The prison chief medical officer was in
charge of clinical examinations. Para-clinical tests (pul-
monary X-ray, Ziehl-Nielsen technique, and auramine
dark-field microscopy performed on sputum) were per-
formed at the provincial laboratory of the National TB
Control Programme. The following characteristics were
taken into account: age, sex, height (meters), weight (kilo-
grams), marital status, level of education, inmate’s status,
length of detention, clinical signs (weight loss, anorexia,
asthenia, duration of cough, fever, thoracic pain, night
sweats, sputum, and hemoptysis) and conditions of deten-
tion (number of detainees per dorm). A dorm was consid-
ered as overcrowded if more than 50 prisoners were
housed in a 40 m2-cell. The body mass index (BMI) char-
acterized inmates’ nutritional status: malnutrition was
assessed by a BMI less than 18.5 kg/m2.
Statistical analyses
Descriptive statistics were first used to analyze the data.
Either a chi-square test or a Fisher exact test was
performed on contingency tables. A univariate analysis
allowed estimating crude odds ratios (OR) and their
95 % confidence intervals (95 % CI). Factors independ-
ently associated with TB occurrence were then investi-
gated through a stepwise logistic regression analysis.
Variables included in the model were selected via a step-
wise procedure based on the likelihood ratios; non-
significant independent variables (p value greater than
0.05) were deleted from the regression model. For each
associated factor, the contribution to the disease popula-
tion attributable fraction (PAF) was estimated after ad-
justment. We calculated the PAF using Levin’s formula:
PAF = Pe (ORe − 1)/[1 + Pe (ORe − 1)]. Pe is the preva-
lence of the exposure, and ORe is the odds ratio of TB
due to that exposure. Results were considered as signifi-
cant for a p value less than 0.05. Statistical analyses were
performed with STATA 12.0 software.
Results
Sociodemographic and clinical features of inmates
Of the 733 prisoners interviewed, 94.8 % were male and
their mean age ± SD was 31 ± 9.5 years old. The median
Table 2 Factors associated with TB occurrence (n = 130)—
univariate analysis





< 30 64 15.7 1
≥ 30 66 20.4 1.4 (0.9–2.0) 0.097
Sex
Male 127 18.3 2.6 (0.7–8.6) 0.116
Female 3 7.8 1
Length of incarceration (months)
< 12 58 13.8 1
≥ 12 72 23.0 1.9 (1.3–2.7) 0.001
BMI (kg/m2)
< 18.5 81 22.0 1.8 (1.2–2.7) 0.003
≥ 18.5 49 13.4 1
Overcrowding (>50 prisoners/40 m2)
Yes 127 20.5 9.4 (2.9–30.2) <0.001
No 3 2.7 1
TB tuberculosis, OR odds ratio, CI confidence interval, BMI body mass index
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months). Malnutrition (BMI less than 18.5 kg/m2) was
noticed in half the inmates. Predominating clinical signs
were weight loss and asthenia, as reported in 85.3 and
61.4 % of prisoners, respectively (Table 1).
Prevalence of tuberculosis and associated
factors—univariate analysis
A diagnosis of TB was made in 130 inmates (23 former
and 107 new cases), which means a 17.7 % prevalence
(95 % CI 15.1–20.6 %). No significant difference was
observed between young (under 30 years of age; 15.7 %)
and old (over 30 years of age; 20.4 %) age groups. Tuber-
culosis particularly affected men, rather than women
(18.3 vs. 7.8 %, respectively), although no significant
difference was highlighted. The following parameters
were considered as risk factors for developing TB, as
shown by the univariate analysis (crude ORs) in Table 2:
malnutrition (BMI less than 18.5 kg/m2 [OR 1.8; 95 %
CI = 1.2–2.7]), a length of detention equal to or greater
than 12 months (OR 1.9; 95 % CI [1.3–2.7]), and over-
crowding (OR 9.4; 95 % CI [2.9–30.2]).
After performing the logistic regression model (multi-
variate analysis), TB remained statistically associated
with the following parameters (Table 3): malnutrition, a
length of detention equal to or greater than 12 months,
and overcrowding (more than 50 prisoners/40 m2). Fac-
tors attributable to the risk of TB in the population (PAF)
were estimated for these three risk factors. OvercrowdingTable 1 Sociodemographic and clinical characteristics of
prisoners (N = 733)
Parameters Number Median (IQR) Mean ± SD Percent
Age (years) 31 ± 9.5
< 30 409 55.8
Sex
Male 695 94.8
Length of incarceration 24 (18–52)
< 12 months 420 57.3
BMI (kg/m2)
< 18.5 368 50.2
Overcrowding (>50 prisoners/40 m2)
Yes 620 84.6
Clinical signs
Cough > 2 weeks 125 17.1
Weight loss 625 85.3
Temperature > 39 °C 115 15.7
Night sweat 109 14.9
Asthenia 450 61.4
Thoracic pain 110 15.0
SD standard deviation, IQR interquartile range, BMI body mass indexshowed the highest PAF (88.2 %), followed by malnutrition
(35.6 %) and a length of detention equal to or greater than
12 months (38.7 %), as shown in Table 3.
Discussion
Our study aimed at estimating TB prevalence (confirmed
by positive microscopy) in the population of Mbuji-Mayi
Central Prison and investigating the possible association
between sociodemographic characteristics of prisoners,
conditions of detention, and occurrence of TB.
The sample included 733 prisoners, mostly men. Tu-
berculosis prevalence (17.7 %) was elevated compared to
other prisons in Africa. Studies in Cameroon (1.2 %), in
Ivory coast (5.8 %), in and Ethiopia (10.4 %) showedTable 3 Factors associated with TB occurrence (n = 130)—
multivariate analysis
Parameter Adjusted OR (95 % CI) p value PAF (%)
Incarceration period (months)
< 12 1
≥ 12 2.1 (1.4–3.1) 0.001 38.7
BMI (kg/m2)
< 18.5 2.1 (1.3–3.0) 0.003 35.6
≥ 18.5 1
Overcrowding (>50 prisoners/40 m2)
Yes 9.8 (3.1–31.6) <0.001 88.2
No 1
PAF population attributable fraction
Hosmer-Lemeshow (HL) test = 1.58; p = 0.063
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prisons compared to our study [3, 8, 16]. The prevalence
in the Mbuji-Mayi Central Prison (130/733 = 17.7 %) is
about 33 times higher than the national average (532/
100,000 = 0.532 %). Our study confirms the conclusions
of a previous Ethiopian survey conducted in 2011, where
TB prevalence in prison was sevenfold higher compared
to the general community [14]. In Brazil, data collected
in Rio state prisons revealed an annual TB prevalence 31
times higher than in the general population, despite the
differences between prisons [17]. Other investigations
reported a TB prevalence above 20 % in some Malawi
prisons [18]. Of 296 Cameroonian individuals tested,
11.5 % were positive for acid-fast bacilli [3]. Combined
to inadequate care, especially in a prison environment,
TB prevalence remains elevated in DRC.
Sociodemographic characteristics of TB patients were
similar to those described in previous studies [17, 19].
Even if no statistical difference was highlighted for age
groups and sex in our study, Lilanganee Telisinghe and
collaborators observed that TB especially affected young
adults, aged between 27 and 37 years old, in South
Africa [20]. Similar trends were observed in Pakistan
and Malawi [21, 22]. The very low sample size of some
categories could likely explain such observation. Accord-
ing to the WHO, the male/female ratio is not relevant
for the disease, as women are often outnumbered by
men in the prison population [23].
The univariate analysis showed that a length of deten-
tion equal to or greater than 12 months is a crucial risk
factor to become infected. Overcrowding was also iden-
tified as a risk factor, and most prisoners were malnour-
ished, as confirmed by a BMI lower than 18.5 kg/m2. A
poor diet increases the risk of contracting TB, as body
defenses are generally lowered, which explains a higher
prevalence of the disease in prison. The same risk factors
were identified in Cameroon, Pakistan, and Zimbabwe
[3, 21, 24] An incarceration in overcrowded cells, a BMI
lower than 18.5 kg/m2, and a prior anti-TB therapy were
also identified as risk factors for TB in prison [16, 19].
Furthermore, Harris and collaborators [25] concluded
that transmission of TB was exacerbated by several
factors in the prison environment: a poor diet, over-
crowding (generating a poor ventilation), HIV, and other
ordinary conditions facilitating the evolution of a latent
TB infection into a clinical disease. These authors
incriminate a poor financial support and the lack of
healthcare organization as factors increasing the prob-
ability of a late diagnosis, incomplete therapy, and facili-
tated transmission. The multivariate analysis confirmed
the observations of the univariate approach. Three
factors were highlighted as risk factors: malnutrition
(low BMI), overcrowding (more than 50 prisoners per
40 m2), and a length of detention equal to or greaterthan 12 months, in accordance with previous reports
[26–28]. These factors showed a very high PAF; their
suppression would prevent 35.6 to 88.2 % of TB cases
recorded in prison. In Mbuji-Mayi prison, overcrowding
is a real concern. The buildings were initially designed
to accommodate 150 inmates; nevertheless, a recent
report mentioned six times as many prisoners [9]. Our
observations confirm that conditions of detention and
promiscuity are a real time-bomb. Overcrowding en-
hances the propagation of diseases, and TB is transmit-
ted much more easily than HIV, as physical contact is
not required. Unclogging the prison would lead to an
84 %-reduction of TB cases and would break the trans-
mission chain between prisoners, staff, and visitors. A
discrimination in the prison itself is often observed.
Many TB patients come from economically disadvan-
taged families, who do not have an easy access to
healthcare and often live in poor hygienic conditions.
Overcrowding was already identified as a risk factor in
previous studies, with the highest PAF compared to
other factors [16, 27, 29, 30].
The socioeconomic situation of DRC and the low op-
erating budget allocated to prisons, in general, explain
the poor quality healthcare. On a daily basis, either hu-
manitarians or families provide food to prisoners, the
latter often being extremely poor. Health professionals
should be more involved in the control of TB in the
prison environment. There is an urgent need for TB
prisoners to be followed and correctly treated in order
to interrupt the transmission chain, especially since re-
sistance to treatment is progressing (as mentioned in the
recent report of the National TB Control Programme).
It is imperative to implement measures enabling a rapid
identification of clinical TB cases in prisoners. If they
are contagious, adequate isolation conditions are re-
quired; therapy should be rapidly implemented as well.
Infection control guidance must not only be written but
also implemented. Tuberculosis control in prisons, and
especially in Mbuji-Mayi, remains a priority and should
be an integral part of any public health policy aiming at
controlling and eradicating the disease. However, basic
hygienic conditions are lacking in prison.
Limitations of the study
The present study investigated the prevalence of TB and
associated risk factors in the context of Mbuji-Mayi
prison. The relationship between TB and HIV and/or
other health problems such as hepatitis were not assessed.
Conclusions
Tuberculosis remains a major public health concern,
exacerbated by the delay and poor quality of diagnosis
combined to a deficient healthcare, particularly in the
prison environment. Tuberculosis is a serious disadvantage
Kalonji et al. Tropical Medicine and Health  (2016) 44:30 Page 5 of 6for developing countries, as it particularly affects young
adults. In our study, we identified three factors independ-
ently associated with TB occurrence: malnutrition, pro-
longed length of detention, and overcrowding. Improving
conditions of detention and providing an adequate and
early healthcare would considerably reduce the incidence
of TB in prison. Efforts aiming at controlling the disease
must include strategies adapted to the prison environment.
Furthermore, it should be the target of a national health
policy supported by international organizations.
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